Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avatrombopag”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableLooking for participantsNCT05823376
What this trial is testing

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 40
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Not applicableUnknownNCT05571332
What this trial is testing

Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function

Who this might be right for
Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 39
Not applicableEnded earlyNCT03554759
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

Who this might be right for
Thrombocytopenia
Sobi, Inc. 50
Testing effectiveness (Phase 2)UnknownNCT05720234
What this trial is testing

Avatrombopag Combined With IST as First-line Treatment for SAA

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 53
Large-scale testing (Phase 3)Study completedNCT01976104
What this trial is testing

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Who this might be right for
Thrombocytopenia Associated With Liver Disease
Eisai Inc. 204
Testing effectiveness (Phase 2)UnknownNCT06004752
What this trial is testing

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT03471078
What this trial is testing

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sobi, Inc. 122
Testing effectiveness (Phase 2)UnknownNCT06254287
What this trial is testing

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA

Who this might be right for
Anemia, Aplastic
Institute of Hematology & Blood Diseases Hospital, China 60
Early research (Phase 1)Study completedNCT02809768
What this trial is testing

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02227693
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

Who this might be right for
Thrombocytopenia Associated With Chronic Liver Disease
Eisai Co., Ltd. 39
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Early research (Phase 1)Study completedNCT01759394
What this trial is testing

A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal

Who this might be right for
Healthy Volunteers
Eisai Inc. 36
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Early research (Phase 1)Study completedNCT02039076
What this trial is testing

A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects

Who this might be right for
Thrombocytopenia
Eisai Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00914927
What this trial is testing

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Eisai Inc. 130
Not applicableStudy completedNCT07600905
What this trial is testing

Avatrombopag for Severe Thrombocytopenia After Liver Transplantation: A Retrospective Cohort Study

Who this might be right for
Liver TransplanatationPostoperative ComplicationSevere Thrombocytopenia
Shanghai Zhongshan Hospital 134
Testing effectiveness (Phase 2)Looking for participantsNCT04993885
What this trial is testing

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune ThrombocytopeniaAutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 52
Testing effectiveness (Phase 2)UnknownNCT04896528
What this trial is testing

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Who this might be right for
ThrombocytopeniaAvatrombopag
Peking Union Medical College Hospital 30
Load More Results